The SGLT2 inhibitor canagliflozin in heart failure: the CHIEF-HF remote, patient-centered randomized trial
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The SGLT2 inhibitor canagliflozin in heart failure: the CHIEF-HF remote, patient-centered randomized trial
Authors
Keywords
-
Journal
NATURE MEDICINE
Volume 28, Issue 4, Pages 809-813
Publisher
Springer Science and Business Media LLC
Online
2022-03-01
DOI
10.1038/s41591-022-01703-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Novel Trial Design: CHIEF-HF
- (2021) John A. Spertus et al. Circulation-Heart Failure
- Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease
- (2021) W. Schuyler Jones et al. NEW ENGLAND JOURNAL OF MEDICINE
- Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial
- (2021) JoAnn Lindenfeld et al. LANCET
- The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial
- (2021) Michael E. Nassif et al. NATURE MEDICINE
- Dapagliflozin Cut Risk of Worsening Heart Failure
- (2020) Anita Slomski JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Heart Failure Collaboratory Statement on Clinical Trials in the Landscape of COVID-19
- (2020) William T. Abraham et al. JACC-Heart Failure
- Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure
- (2020) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- New Guidelines for Statistical Reporting in the Journal
- (2019) David Harrington et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial
- (2019) Michael E. Nassif et al. CIRCULATION
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Dapagliflozin on Symptoms, Function and Quality of Life in Patients with Heart Failure and Reduced Ejection Fraction: Results from the DAPA-HF Trial
- (2019) Mikhail N. Kosiborod et al. CIRCULATION
- The potential role and rationale for treatment of heart failure with sodium-glucose co-transporter 2 inhibitors
- (2017) Javed Butler et al. EUROPEAN JOURNAL OF HEART FAILURE
- Efficient design of clinical trials and epidemiological research: is it possible?
- (2017) Michael S. Lauer et al. Nature Reviews Cardiology
- Association of Serial Kansas City Cardiomyopathy Questionnaire Assessments With Death and Hospitalization in Patients With Heart Failure With Preserved and Reduced Ejection Fraction
- (2017) Yashashwi Pokharel et al. JAMA Cardiology
- Trends in Heart Failure Clinical Trials From 2001–2012
- (2016) Ayman Samman Tahhan et al. JOURNAL OF CARDIAC FAILURE
- Quantifying clinical change: discrepancies between patients’ and providers’ perspectives
- (2016) Rachel P. Dreyer et al. QUALITY OF LIFE RESEARCH
- Development and Validation of a Short Version of the Kansas City Cardiomyopathy Questionnaire
- (2015) John A. Spertus et al.
- Cardiovascular Drug Development
- (2015) Christopher B. Fordyce et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Development and Validation of a Short Version of the Kansas City Cardiomyopathy Questionnaire
- (2015) John A. Spertus et al. Circulation-Cardiovascular Quality and Outcomes
- Comparable Performance of the Kansas City Cardiomyopathy Questionnaire in Patients With Heart Failure With Preserved and Reduced Ejection Fraction
- (2013) Susan M. Joseph et al. Circulation-Heart Failure
- Transforming Clinical Trials in Cardiovascular Disease
- (2012) Elliott M. Antman et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Thrombus Aspiration in ST-Elevation myocardial infarction in Scandinavia (TASTE trial). A multicenter, prospective, randomized, controlled clinical registry trial based on the Swedish angiography and angioplasty registry (SCAAR) platform. Study design and rationale
- (2010) Ole Fröbert et al. AMERICAN HEART JOURNAL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started